ASCO 2020: Personalised treatment strategies in melanoma could reduce toxicity burden from immunotherapy without compromising benefits

In the upcoming years, optimising the use of ICIs will be crucial in the treatment of melanoma. Credit: Shutterstock



  • asco 2020 melanoma